Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

CCL21 and Dendritic Cell Suppression in Paediatric B Cell Acute Lymphoblastic Leukaemia

Russell D Keenan, MBChB, PhD FRCP, FRCPath, Kate LE Phillips, PhD

Blood (2019) 134 (Supplement_1): 3959.

https://doi.org/10.1182/blood-2019-130093

Published: 2019

Journal Articles

Minimising Transfusion Therapy and Alloimmunisation in Patients with Sickle Cell Disorder in the Era of Hydroxyurea

Louise Smith, RCN MSc, Lucy Stead, Russell D Keenan, MBChB, PhD FRCP, FRCPath, Rekha Thangavelu, MB ChB FRCP FRCPath

Blood (2018) 132 (Supplement 1): 5078.

https://doi.org/10.1182/blood-2018-99-119837

Published: 2018

Journal Articles

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Louise Smith, RCN MSc, Elizabeth Ryan, MB ChB, Russell D Keenan, MBChB, PhD FRCP, FRCPath, Rekha Thangavelu, MB ChB FRCP FRCPath

Blood (2018) 132 (Supplement 1): 4927.

https://doi.org/10.1182/blood-2018-99-119768

Published: 2018

Journal Articles

Stopping Folic Acid Supplementation in Hydroxyurea Treated Children with Sickle Cell Disease

Louise Smith, RCN MSc, Amy Littler, RCN, Kate LE Phillips, PhD, Russell D Keenan, MBChB, PhD FRCP, FRCPath

Blood (2017) 130 (Supplement 1): 3546.

https://doi.org/10.1182/blood.V130.Suppl_1.3546.3546

Published: 2017

Journal Articles

Hydroxyurea Therapy Prevents High Risk Trans-Cranial Doppler Development in Children with Sickle Cell Disorders

Indrani Karpha, MPhil, MRCP, MBBS, Louise Smith, RCN MSc, Lawrence Abernathy, FRCR, Kate LE Phillips, PhD, Russell D Keenan, MBChB, PhD FRCP, FRCPath

Blood (2017) 130 (Supplement 1): 977.

https://doi.org/10.1182/blood.V130.Suppl_1.977.977

Published: 2017

Journal Articles

Geophagia: A Scientific Approach to a Historical Practice to Sustainably Treat Endemic Iron Deficiency in a Rural Community in Nepal

Binay Lama, Rachael Jones, MSc, Nicola Barlow, MChem, DPhil, MSc, FRCPath, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2016) 128 (22): 2346.

https://doi.org/10.1182/blood.V128.22.2346.2346

Published: 2016

Journal Articles

Potential for Dendritic Cell Stimulated De Novo Anti-Leukaemia CD4 T Cell Response in the Bone Marrow Tumour Microenvironment during Induction Chemotherapy

Kate L E Phillips, PhD, Joanne E Dean, BSc, Brian F Flanagan, PhD, Steve E Christmas, DPhil, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2016) 128 (22): 2524.

https://doi.org/10.1182/blood.V128.22.2524.2524

Published: 2016

Journal Articles

Single Centre Audit of Testicular Examination Practice in Children with Acute Lymphoblastic Leukaemia

Isobelle Wardach, MRCPCH, MBChB, BSc, Aisha Aslam, MB ChB, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2016) 128 (22): 5159.

https://doi.org/10.1182/blood.V128.22.5159.5159

Published: 2016

Journal Articles

Normal Lymphocytes at Diagnosis and during Induction Chemotherapy in Childhood Acute Lymphoblastic Leukaemia in Peripheral Blood and Bone Marrow Are Predominantly CD3+, CD4+ or CD8+, CCR7+, CD45RA+, HLA-DR-

Kate L E Phillips, PhD, Steve E Christmas, DPhil, Brian F Flanagan, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 4982.

https://doi.org/10.1182/blood.V126.23.4982.4982

Published: 2015

Journal Articles

Application of Human Immunophenotyping Consortium Panels to Early Childhood Leukaemia; From Diagnosis to End of Induction Chemotherapy

Kate L E Phillips, PhD, Steve E Christmas, DPhil, Brian F Flanagan, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 4995.

https://doi.org/10.1182/blood.V126.23.4995.4995

Published: 2015

Journal Articles

Hyperhaemolysis in Sickle Cell Disease Is Not Necessarily a Transfusion Reaction

Elizabeth A Jones, MB ChB MRCPCH FRCPath, Louise Smith, RCN MSc, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 4595.

https://doi.org/10.1182/blood.V126.23.4595.4595

Published: 2015

Journal Articles

Hydroxyurea Therapy for Sickle Cell Disorders in Childhood: Adherence to Therapy Transforms Lives and Needs to be the Focus - the Experience of Alder Hey Children's Hospital

Louise Smith, RCN MSc, Kate L E Phillips, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 990.

https://doi.org/10.1182/blood.V126.23.990.990

Published: 2015

Journal Articles

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters, Jan Astermark, Paul P. Brons, Giancarlo Castaman, Marjon H. Cnossen, Natasja Dors, Carmen Escuriola-Ettingshausen, Karly Hamulyak, Daniel P. Hart, Charles R. M. Hay, Saturnino Haya, Waander L. van Heerde, Cedric Hermans, Margareta Holmström, Victor Jimenez-Yuste, Russell D. Keenan, Robert Klamroth, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Ri Liesner, Anne Mäkipernaa, Christoph Male, Evelien Mauser-Bunschoten, Maria G. Mazzucconi, Simon McRae, Karina Meijer, Michael Mitchell, Massimo Morfini, Marten Nijziel, Johannes Oldenburg, Kathelijne Peerlinck, Pia Petrini, Helena Platokouki, Sylvia E. Reitter-Pfoertner, Elena Santagostino, Piercarla Schinco, Frans J. Smiers, Berthold Siegmund, Annarita Tagliaferri, Thynn T. Yee, Pieter Willem Kamphuisen, Johanna G. van der Bom, Karin Fijnvandraat

Blood (2013) 122 (11): 1954–1962.

https://doi.org/10.1182/blood-2013-02-483263

Published: 2013

Includes: Supplemental data

Journal Articles

Ataxia telangiectasia mutated–deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage

Tatjana Stankovic, Grant S. Stewart, Christopher Fegan, Paul Biggs, James Last, Philip J. Byrd, Russell D. Keenan, Paul A. H. Moss, Alexander M. R. Taylor

Blood (2002) 99 (1): 300–309.

https://doi.org/10.1182/blood.V99.1.300

Published: 2002

NARROW

CCL21 and Dendritic Cell Suppression in Paediatric B Cell Acute Lymphoblastic Leukaemia

Minimising Transfusion Therapy and Alloimmunisation in Patients with Sickle Cell Disorder in the Era of Hydroxyurea

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Stopping Folic Acid Supplementation in Hydroxyurea Treated Children with Sickle Cell Disease

Hydroxyurea Therapy Prevents High Risk Trans-Cranial Doppler Development in Children with Sickle Cell Disorders

Geophagia: A Scientific Approach to a Historical Practice to Sustainably Treat Endemic Iron Deficiency in a Rural Community in Nepal

Potential for Dendritic Cell Stimulated De Novo Anti-Leukaemia CD4 T Cell Response in the Bone Marrow Tumour Microenvironment during Induction Chemotherapy

Single Centre Audit of Testicular Examination Practice in Children with Acute Lymphoblastic Leukaemia

Normal Lymphocytes at Diagnosis and during Induction Chemotherapy in Childhood Acute Lymphoblastic Leukaemia in Peripheral Blood and Bone Marrow Are Predominantly CD3+, CD4+ or CD8+, CCR7+, CD45RA+, HLA-DR-

Application of Human Immunophenotyping Consortium Panels to Early Childhood Leukaemia; From Diagnosis to End of Induction Chemotherapy

Hyperhaemolysis in Sickle Cell Disease Is Not Necessarily a Transfusion Reaction

Hydroxyurea Therapy for Sickle Cell Disorders in Childhood: Adherence to Therapy Transforms Lives and Needs to be the Focus - the Experience of Alder Hey Children's Hospital

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Ataxia telangiectasia mutated–deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only